News

The Phase I study, conducted in France, assessed the safety, tolerability, pharmacokinetics and pharmacodynamics of SCYX-7158 after single oral ascending doses in 128 healthy human volunteers of sub-Saharan

Insulin glargine 300 units/mL is a concentrated formulation of the glargine molecule identified in Lantus (insulin glargine 100 units/mL). It forms a compact subcutaneous depot with a reduced

The companies will commence pre-clinical animal studies in Duchenne Muscular Dystrophy (DMD). The collaboration aims to expand existing preclinical proof of concept data in additional DMD animal models.

Under the research collaboration, scientists at both the companies will evaluate potential novel mechanisms as targeted anti-fibrotics in multi-organ fibrosis. Evotec will deliver its drug discovery platform whereas

When fully operational in 2017, the factory will make more than 8 billion tablets and 1 billion capsules in the areas of gastroenterology and anti-inflammatory medicines for the

Exploration into cell metabolism is rapidly accelerating as the links between mitochondrial function and disease are increasingly revealed. Seahorse Bioscience’s leading technology enables researchers to better understand cell

The research collaboration will be undertaken at MIT in Boston, US and Novo’s research facilities in Måløv and Hillerød, Denmark. It intends to develop the next generation of

As part of this arrangement, Recipharm will also acquire Alcon’s manufacturing facility located in Kaysersberg, France. The 260 people currently employed at the Kaysersberg site would transfer and

The office said it did not improve the efficacy of the current approved drug. Indian Patent Office assistant controller of patents and designs Bharat N.S said in an